Cargando…
Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy
Bispecific antibodies (BsAbs) bind to two different targets, and create two binary and one ternary complex (TC). These molecules have shown promise as immuno‐oncology drugs, and the TC is considered the pharmacologically active species that drives their pharmacodynamic effect. Here, we have presente...
Autores principales: | Schropp, Johannes, Khot, Antari, Shah, Dhaval K., Koch, Gilbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430159/ https://www.ncbi.nlm.nih.gov/pubmed/30480383 http://dx.doi.org/10.1002/psp4.12369 |
Ejemplares similares
-
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
por: Bachmann, Freya, et al.
Publicado: (2021) -
Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules
por: Datta-Mannan, Amita, et al.
Publicado: (2021) -
Effect of variable domain charge on in vitro and in vivo disposition of monoclonal antibodies
por: Liu, Shufang, et al.
Publicado: (2021) -
Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody
por: Wang, Yan, et al.
Publicado: (2020) -
Model-Based Assessment of Dosing Strategies in Children for Monoclonal Antibodies Exhibiting Target-Mediated Drug Disposition
por: Zheng, S, et al.
Publicado: (2014)